Zdrowie i gospodarka · 26/07/1999

FDA Releases Draft Guidance on Monoclonal Antibody Products Under Orphan Drug Regulations

The Food and Drug Administration (FDA) has released a draft document outlining its criteria for determining the sameness of monoclonal antibody products under the Orphan Drug Act and implementing regulations, aimed at providing clarity for sponsors and manufacturers.